Iktos Raises €15.5m Series A Round To Expand Ai Drug Discovery Technologies

Iktos, a company specialising in artificial intelligence for new drug discovery, has announced the closing of a €15.5m Series A financing round co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. The funding will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service. The solutions developed by Iktos are aimed to speed up the drug discovery process and increase the probability of success of drug candidates reaching clinical development.